- 関
- betaxolol
WordNet
- a complex consisting of an organic base in association with hydrogen chloride
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/05/08 07:02:04」(JST)
[Wiki en表示]
Betaxolol
|
|
Systematic (IUPAC) name |
(RS)-1-{4-[2-(cyclopropylmethoxy)ethyl]-
phenoxy}-3-(isopropylamino)propan-2-ol |
Clinical data |
Trade names |
Kerlone |
AHFS/Drugs.com |
monograph |
MedlinePlus |
a609023 |
Pregnancy cat. |
C (AU) C (US) |
Legal status |
℞ Prescription only |
Routes |
oral, ocular |
Pharmacokinetic data |
Bioavailability |
89% |
Metabolism |
Hepatic |
Half-life |
14–22 hours |
Excretion |
Renal (20%) |
Identifiers |
CAS number |
63659-18-7 Y |
ATC code |
C07AB05 S01ED02 |
PubChem |
CID 2369 |
IUPHAR ligand |
549 |
DrugBank |
DB00195 |
ChemSpider |
2279 Y |
UNII |
O0ZR1R6RZ2 Y |
KEGG |
D07526 Y |
ChEBI |
CHEBI:3082 Y |
ChEMBL |
CHEMBL423 Y |
Chemical data |
Formula |
C18H29NO3 |
Mol. mass |
307.428 g/mol |
SMILES
- O(CCc1ccc(OCC(O)CNC(C)C)cc1)CC2CC2
|
InChI
-
InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3 Y
Key:NWIUTZDMDHAVTP-UHFFFAOYSA-N Y
|
Y (what is this?) (verify) |
Betaxolol (trade names Betoptic, Betoptic S, Lokren, Kerlone) is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma. Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as timolol may. Betaxolol also shows greater affininty for beta1 receptors than metoprolol. In addition to its effect on the heart, betaxolol reduces the pressure within the eye (intraocular pressure). This effect is thought to be caused by reducing the production of the liquid (which is called the aqueous humor) within the eye. The precise mechanism of this effect is not known. The reduction in intraocular pressure reduces the risk of damage to the optic nerve and loss of vision in patients with elevated intraocular pressure due to glaucoma.
Betaxolol was approved by the U.S. Food and Drug Administration (FDA) for ocular use as a 0.5% solution (Betoptic) in 1985 and as a 0.25% solution (Betoptic S) in 1989.
Contents
- 1 Clinical uses
- 2 Dosage
- 3 Contraindications
- 4 External links
- 5 See also
Clinical uses
- Oral: for the management of hypertension
- Ophthalmic: for the management of glaucoma
- the drug seems to have an effect of neuroprotection in glaucoma treatment
Dosage
- Oral: The initial dose in hypertension is ordinarily 10 mg once daily either alone or added to diuretic therapy.
- Ophthalmic: The recommended dose one to two drops in the affected eye(s) twice daily.
Contraindications
- Hypersensitivity to the drug
- Patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure
External links
- Kerlone prescribing information
See also
Levobetaxolol
Beta blockers (C07)
|
|
Beta, nonselective |
- Alprenolol
- Bopindolol
- Bupranolol
- Carteolol
- Cloranolol
- Mepindolol
- Nadolol
- Oxprenolol
- Penbutolol
- Pindolol
- Propranolol
- Sotalol
- Tertatolol
- Timolol
|
|
Beta1 selective |
- Acebutolol
- Atenolol
- Betaxolol
- Bevantolol
- Bisoprolol
- Celiprolol
- Epanolol
- Esmolol
- Nebivolol
- Metoprolol
- Practolol
- S-atenolol
- Talinolol
|
|
Alpha + beta |
|
|
Other/ungrouped |
|
|
|
anat (a:h/u/t/a/l,v:h/u/t/a/l)/phys/devp/cell/prot
|
noco/syva/cong/lyvd/tumr, sysi/epon, injr
|
proc, drug (C2s+n/3/4/5/7/8/9)
|
|
|
|
Ophthalmologicals: antiglaucoma preparations and miotics (S01E)
|
|
Sympathomimetics |
- Apraclonidine
- Brimonidine (+timolol)
- Clonidine
- Dipivefrine
- Epinephrine
|
|
Parasympathomimetics |
muscarinic
|
|
|
muscarinic/nicotinic
|
|
|
Acetylcholinesterase inhibitors
|
- Demecarium
- Ecothiopate
- Stigmine (Fluostigmine
- Neostigmine
- Physostigmine)
- Paraoxon
|
|
|
Carbonic anhydrase inhibitors/
(sulfonamides) |
- Acetazolamide
- Brinzolamide (+timolol)
- Diclofenamide
- Dorzolamide (+timolol)
- Methazolamide
|
|
Beta blocking agents |
- Befunolol
- Betaxolol
- Carteolol
- Levobunolol
- Metipranolol
- Timolol
- Mepindolol
|
|
Prostaglandin analogues (F2α) |
- Bimatoprost (+timolol)
- Latanoprost (+timolol)
- Tafluprost
- Travoprost (+timolol)
- Unoprostone
|
|
Other agents |
|
|
|
anat (g/a/p)/phys/devp/prot
|
|
proc, drug (S1A/1E/1F/1L)
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Electrically enhanced microextraction for highly selective transport of three β-blocker drugs.
- Seidi S, Yamini Y, Rezazadeh M.SourceDepartment of Chemistry, Tarbiat Modares University, P.O. Box 14115-175, Tehran, Iran.
- Journal of pharmaceutical and biomedical analysis.J Pharm Biomed Anal.2011 Dec 15;56(5):859-66. Epub 2011 Jul 29.
- Facilitated transport of three β-blocker drugs including atenolol (ATE), betaxolol (BET) and propranolol (PRO) was investigated under electrical field across a supported liquid membrane (SLM) using phosphoric acid derivatives as selective ion carriers, dissolved in 2-nitro phenyl octyl ether (NPOE)
- PMID 21856103
- Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
- Heijl A, Leske MC, Hyman L, Yang Z, Bengtsson B; EMGT Group.SourceDepartment of Ophthalmology, Lund University, Malmö University Hospital, Malmö, Sweden. anders.heijl@med.lu.se
- Acta ophthalmologica.Acta Ophthalmol.2011 Dec;89(8):749-54. doi: 10.1111/j.1755-3768.2009.01852.x. Epub 2010 Mar 17.
- PURPOSE: To evaluate: (i) the relationship between intraocular pressure (IOP) reduction attained with a fixed treatment protocol and the untreated IOP level; (ii) the consistency of IOP reduction over time; and (iii) whether there is a threshold pretreatment IOP level below which IOP reduction might
- PMID 20236252
- Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin.
- Baek SD, Jang SJ, Park SE, Ok TJ, Leem J, Lee HS, Park SJ, Kim TH.SourceDepartment of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Journal of Korean medical science.J Korean Med Sci.2011 Dec;26(12):1634-7. Epub 2011 Nov 29.
- HMG-CoA reductase inhibitors (statins) are widely used to treat hypercholesterolemia. Among the adverse effects associated with these drugs are statin-associated myopathies, ranging from asymptomatic elevation of serum creatine kinase to fatal rhabdomyolysis. Fluvastatin-induced fatal rhabdomyolysis
- PMID 22148003
Japanese Journal
- Effect of Betaxolol Hydrochloride on Heart Rate Variability Indices during Exercise Stress Testing in Hypertensive Patients(Exercise Test/Cardiac Rehabilitation 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Takase Bonpei,Hamane Akira,Akima Takashi,Matsui Takemi,Arakawa Koh,Kusuhara Masatoshi,Ohsuzu Fumitaka,Ishihara Masayuki,Kuirta Akira
- Circulation journal : official journal of the Japanese Circulation Society 69(Supplemnt_I), 425, 2005-03-01
- NAID 110004053194
- Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers
- 正常眼圧緑内障患者におけるβ-ブロッカー点眼薬ノンレスポンダーの検討
- 池田 陽子,森 和彦,石橋 健,成瀬 繁太,小林 ルミ,南條 由佳子,水野 秀信,中島 伸子,木下 茂
- あたらしい眼科 = Journal of the eye 20(10), 1435-1437, 2003-10-30
- NAID 10017018173
Related Links
- Betaxolol Hydrochloride reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI). ... Betaxolol Hydrochloride Pharmacokinetics Absorption Bioavailability Well absorbed following ...
- Sigma-Aldrich offers Sigma-B5683, Betaxolol hydrochloride for your research needs. Find product specific information including CAS, MSDS, protocols and references. ... Biochem/physiol Actions Selective β 1 adrenoceptor ...
Related Pictures
★リンクテーブル★
[★]
- 英
- betaxolol
- 化
- 塩酸ベタキソロール betaxolol hydrochloride
- 商
- アロング、ケフナン、ケルロング、タルロング、ベタキール、ベタキソン、ベトプティック、ベトプティックエス
- 関
- 眼科用剤
[★]
ベタキソロール
- 関
- betaxolol hydrochloride
[★]
塩酸塩、ハイドロクロライド